electroCore: Promising Product Means New Management Team Can Complete Unlikely TurnaroundSeeking Alpha • 05/28/20
electroCore, Inc. (ECOR) CEO Dan Goldberger on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/15/20
electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in the U.K.GlobeNewsWire • 04/08/20
electroCore Submits Emergency Use Authorization Application to Allow the Study and Use of gammaCore nVNS Therapy to Treat Respiratory Symptoms Associated with COVID-19GlobeNewsWire • 04/02/20
electroCore Announces 510(k) Clearance of gammaCore™ Label Expansion into Migraine PreventionGlobeNewsWire • 03/30/20
electroCore Announces Common Stock Purchase Agreement for up to $25 Million with Lincoln Park CapitalGlobeNewsWire • 03/27/20
electroCore, Inc. (ECOR) CEO Dan Goldberger on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/24/20
electroCore, Inc. Announces Rebate Agreement with Ascent Health Services for gammaCore Preferred Brand Coverage on all Express Scripts Standard National FormulariesGlobeNewsWire • 01/27/20
NICE Recommends the Use of gammaCore for the Treatment of Cluster Headache in the NHSGlobeNewsWire • 12/03/19
electroCore's (ECOR) CEO Dan Goldberger on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/14/19
electroCore Appoints Medical Technology Veteran Daniel S. Goldberger as Chief Executive OfficerGlobeNewsWire • 09/30/19